MK-1084: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
3
Conditions studied
5
US states with sites
16
Countries
Phase breakdown
Phase 1 1
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer | 2 |
| Lung Neoplasm Malignant | 1 |
| Malignant Neoplasm | 1 |
Recruiting trials involving MK-1084
- A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
- KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Common questions
How many recruiting trials involve MK-1084?
2 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.